As a Scientist I at Laverock Therapeutics, I specialize in integrating cutting-edge automation into our RNA construct screening and iPSC workflows. I’ve been instrumental in establishing high-throughput RNA construct screening approaches, which have drastically scaled up our gene silencing capabilities. A key focus of my work has been on implementing advanced liquid handling-based automation for iPSC cell culture, enabling the efficient production of gene-edited iPSCs. This automation is revolutionizing our processes, driving unprecedented speed and precision in our gene editing efforts. I am passionate about pushing the boundaries of biotechnology through innovative automation, paving the way for new advancements in cell and gene therapy.